Reviewed,
UniProtKB/Swiss-Prot P06493 (CDC2_HUMAN)
Last modified
July 22, 2008.
Version 121.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Cell division control protein 2 homolog EC=2.7.11.22 EC=2.7.11.23 Alternative name(s): p34 protein kinase Cyclin-dependent kinase 1 Short name(s)=CDK1 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 297 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Plays a key role in the control of the eukaryotic cell cycle. It is required in higher cells for entry into S-phase and mitosis. p34 is a component of the kinase complex that phosphorylates the repetitive C-terminus of RNA polymerase II. |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. ATP + [DNA-directed RNA polymerase] = ADP + [DNA-directed RNA polymerase] phosphate. |
| Enzyme regulation | Phosphorylation at Thr-14 or Tyr-15 inactivates the enzyme, while phosphorylation at Thr-161 activates it. |
| Subunit structure | Forms a stable but non-covalent complex with a regulatory subunit and with a cyclin. Interacts with DLGAP5. Isoform 2 is unable to complex with cyclin B1 and also fails to bind to the CDK inhibitor p21. Interacts with catalytically active CCNB1 and RALBP1 during mitosis to form an endocytotic complex during interphase. |
| Subcellular location | NucleusBy similarity. |
| Sequence similarities | Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily. Contains 1 protein kinase domain. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| AURKB | Q96GD4 | 1 | EBI-444308,EBI-624291 | |
| BIRC5 | O15392 | 1 | EBI-444308,EBI-518823 | |
| Birc6 | O88738 | 1 | EBI-444308,EBI-912068 | From a different organism. |
| CCNB1 | P14635 | 1 | EBI-444308,EBI-495332 | |
| CDC25C | P30307 | 1 | EBI-444308,EBI-974439 | |
| FOXO1 | Q12778 | 4 | EBI-444308,EBI-1108782 | |
| HMGA1 | P17096-1 | 1 | EBI-444308,EBI-746854 | |
| INCENP | Q9NQS7 | 1 | EBI-444308,EBI-307907 | |
| LATS1 | O95835 | 1 | EBI-444308,EBI-444209 | |
| MYT1 | Q01538 | 1 | EBI-444308,EBI-515143 | |
| NDE1 | Q9NXR1 | 1 | EBI-444308,EBI-941227 | |
| NDEL1 | Q9GZM8 | 1 | EBI-444308,EBI-928842 | |
| PPP1CA | P62136 | 1 | EBI-444308,EBI-357253 | |
| PPP1CC | P36873-1 | 1 | EBI-444308,EBI-356289 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | |||||
| Isoform 1 (identifier: P06493-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | |||||
| Isoform 2 (identifier: P06493-2) Also known as: CDC2deltaT; The sequence of this isoform differs from the canonical sequence as follows: 107-163: Missing. | |||||
| Notes: Found in breast cancer tissues. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 297 | 297 | Cell division control protein 2 homolog | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 4 – 287 | 284 | Protein kinase | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 10 – 18 | 9 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 128 | 1 | Proton acceptor By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 33 | 1 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 14 | 1 | Phosphothreonine | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 15 | 1 | Phosphotyrosine | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 19 | 1 | Phosphotyrosine | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 160 | 1 | Phosphotyrosine | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 161 | 1 | Phosphothreonine | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 107 – 163 | 57 | Missing in isoform 2. | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 4 – 12 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 14 – 23 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 24 – 26 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 29 – 36 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 39 – 42 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 46 – 57 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 66 – 71 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 73 – 81 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 84 – 86 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 87 – 93 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 94 – 96 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 102 – 121 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 133 – 136 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 142 – 144 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 167 – 169 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 172 – 176 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 184 – 199 | 16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 209 – 220 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 225 – 227 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 234 – 236 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 249 – 252 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 253 – 255 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 258 – 267 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 272 – 274 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 278 – 283 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 285 – 287 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2." Lee M.G., Nurse P. Nature 327:31-35(1987) [PubMed: 3553962] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p21." Ohta T., Okamoto K., Isohashi F., Shibata K., Fukuda M., Yamaguchi S., Xiong Y. Cancer Res. 58:1095-1098(1998) [PubMed: 9515786] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). Tissue: Mammary cancer. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [4] | "NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu)." Rieder M.J., Livingston R.J., Braun A.C., Montoya M.A., Chung M.-W., Miyamoto K.E., Nguyen C.P., Nguyen D.A., Poel C.L., Robertson P.D., Schackwitz W.S., Sherwood J.K., Witrak L.A., Nickerson D.A. Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Skin. |
| [6] | "Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement." Draetta G., Beach D. Cell 54:17-26(1988) [PubMed: 3289755] [Abstract] Cited for: PHOSPHORYLATION, ASSOCIATION WITH P13. |
| [7] | "RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis." Rosse C., L'Hoste S., Offner N., Picard A., Camonis J. J. Biol. Chem. 278:30597-30604(2003) [PubMed: 12775724] [Abstract] Cited for: INTERACTION WITH RALBP1. |
| [8] | "Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region." Hsu J.-M., Lee Y.-C.G., Yu C.-T.R., Huang C.-Y.F. J. Biol. Chem. 279:32592-32602(2004) [PubMed: 15145941] [Abstract] Cited for: INTERACTION WITH DLGAP5. |
| [9] | "Global phosphoproteome of HT-29 human colon adenocarcinoma cells." Kim J.-E., Tannenbaum S.R., White F.M. J. Proteome Res. 4:1339-1346(2005) [PubMed: 16083285] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND TYR-15, MASS SPECTROMETRY. |
| [10] | "Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules." Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J., Lauffenburger D.A., White F.M. Mol. Cell. Proteomics 4:1240-1250(2005) [PubMed: 15951569] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, MASS SPECTROMETRY. Tissue: Epithelium. |
| [11] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15 AND TYR-19, MASS SPECTROMETRY. |
| [12] | "Phosphoproteome analysis of the human mitotic spindle." Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R. Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006) [PubMed: 16565220] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161, MASS SPECTROMETRY. Tissue: Epithelium. |
| [13] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed: 17487921] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14 AND TYR-15, MASS SPECTROMETRY. |
| [14] | "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra." Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D. J. Proteome Res. 6:4150-4162(2007) [PubMed: 17924679] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-161, MASS SPECTROMETRY. Tissue: Epithelium. |
| [15] | "Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry." Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R., Keri G., Wehland J., Daub H. Mol. Cell. Proteomics 6:537-547(2007) [PubMed: 17192257] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15 AND TYR-19, MASS SPECTROMETRY. |
| [16] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-160 AND THR-161, MASS SPECTROMETRY. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X05360 mRNA. Translation: CAA28963.1. Y00272 mRNA. Translation: CAA68376.1. D88357 mRNA. Translation: BAA26001.1. AF512554 Genomic DNA. Translation: AAM34793.1. BT007004 mRNA. Translation: AAP35650.1. BC014563 mRNA. Translation: AAH14563.1. | |||||||||||||
| PIR | A29539. | ||||||||||||
| RefSeq | NP_001777.1. NP_203698.1. | ||||||||||||
| UniGene | Hs.334562 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP:35N. | ||||||||||||
| IntAct | P06493. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | P06493. | ||||||||||||
Polymorphism databases | |||||||||||||
| NIEHS-SNPs | Search... | ||||||||||||
2-D gel databases | |||||||||||||
| SWISS-2DPAGE | P06493. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENSG00000170312. Homo sapiens. [Contig view] | ||||||||||||
| GeneID | 983. | ||||||||||||
| KEGG | hsa:983. | ||||||||||||
Organism-specific databases | |||||||||||||
| H-InvDB | HIX0008851. | ||||||||||||
| HGNC | HGNC:1722. CDC2. | ||||||||||||
| HPA | CAB003799. HPA003387. | ||||||||||||
| MIM | 116940. gene. | ||||||||||||
| PharmGKB | PA99. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
| GeneCards | Search... | ||||||||||||
| GeneLynx | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOVERGEN | P06493. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_152. Cell Cycle, Mitotic. REACT_1538. Cell Cycle Checkpoints. REACT_6850. Cdc20:Phospho-APC/C mediated degradation of Cyclin A. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P06493. | ||||||||||||
| CleanEx | HS_CDC2. | ||||||||||||
| GermOnline | ENSG00000170312. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR000719. Prot_kinase_core. IPR017441. Protein_kinase_ATP_bd_CS. IPR017442. Se/Thr_pkinase-rel. IPR008271. Ser_thr_pkin_AS. IPR002290. Ser_thr_pkinase. [Graphical view] | ||||||||||||
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] | ||||||||||||
| ProDom | PD000001. Prot_kinase. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] | ||||||||||||
| BLOCKS | Search... | ||||||||||||
Other Resources | |||||||||||||
| BindingDB | P06493. | ||||||||||||
| SOURCE | |||||||||||||

Clusters with